Drug Shortage Report for DELATESTRYL

Last updated on 2023-05-31 History
Report ID 191622
Drug Identification Number 00029246
Brand name DELATESTRYL
Common or Proper name DELATESTRYL
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) TESTOSTERONE ENANTHATE
Strength(s) 200MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size n/a
ATC code G03BA
ATC description ANDROGENS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-05-04
Estimated end date 2023-06-07
Actual end date 2023-05-30
Shortage status Resolved
Updated date 2023-05-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2023-05-31 English Compare
v5 2023-05-30 French Compare
v4 2023-05-30 English Compare
v3 2023-05-05 English Compare
v2 2023-05-04 French Compare
v1 2023-05-04 English Compare

Showing 1 to 6 of 6